ICI 204,448

CAS No. 121264-04-8

ICI 204,448( —— )

Catalog No. M33869 CAS No. 121264-04-8

ICI 204,448 is a potent κ-opioid agonist with potential analgesic activity for the study of neurological diseases.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 75 In Stock
10MG 119 In Stock
25MG 198 In Stock
50MG 295 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ICI 204,448
  • Note
    Research use only, not for human use.
  • Brief Description
    ICI 204,448 is a potent κ-opioid agonist with potential analgesic activity for the study of neurological diseases.
  • Description
    ICI-204448 is a κ-opioid agonist with limited access to the CNS, ICI-204448 can displace the binding of the kappa-opioid ligand 3H-bremazocine from guinea pig cerebellum membranes.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    Opioid Receptor
  • Recptor
    Opioid Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    121264-04-8
  • Formula Weight
    501.83
  • Molecular Formula
    C23H27Cl3N2O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (249.09 mM; Ultrasonic )
  • SMILES
    Cl.O=C(O)COC1=CC=CC(=C1)C(N(C(=O)CC2=CC=C(Cl)C(Cl)=C2)C)CN3CCCC3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. J S Shaw, et, al. ICI 204448: a kappa-opioid agonist with limited access to the CNS. Br J Pharmacol. 1989, 96, 4.?
molnova catalog
related products
  • Eluxadoline

    A potent, selective, orally bioavailable μ-opioid receptor agonist and a δ-opioid receptor antagonist for the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D).

  • Ac-RYYRIK-NH2

    High affinity ligand for the NOP site (Ki = 1.5 nM). Antagonizes nociceptin-stimulated GTP binding in rat brain and the chronotropic effect of nociceptin on rat cardiomyocytes. However, displays potent agonist properties in vivo, inhibiting locomotor activity in mice.

  • CTAP(TFA)

    CTAP TFA is a potent, highly selective, and brain penetrant ?antagonist of μ-opioid receptor with IC50 of 3.5 nM.?It displays over 1200-fold selectivity over δ opioid (IC50=4500 nM) and somatostatin receptors.